WHO-klassificeringen i 2008 af lymfoide neoplasmer og fortid: ideer under udvikling og fornuftige formål
Verdenssundhedsorganisationens klassificering af lymfoide neoplasmer opdateret i 2008 repræsenterer en verdensomspændende enighed om diagnosen af disse tumorer og er baseret på anerkendelsen af forskellige sygdomme ved hjælp af en tværfaglig tilgang. Den opdaterede klassificering forbedrede definitionerne af velkendte sygdomme, identificerede nye enheder og varianter og inkorporerede nye begreber i forståelsen af lymfoide neoplasmer.
- Nogle spørgsmål var imidlertid uafviklede, såsom i hvilket omfang specifikke genetiske eller molekylære ændringer definerer visse tumorer, og standing som foreløbige enheder, kategorier, som arbejdsgrupperne fra Verdenssundhedsorganisationen mente, at der ikke var tilstrækkelig bevis til at anerkende som forskellige sygdomme ved dette tid.
- Derudover er der siden offentliggørelsen blevet genereret nye fund og ideer. Denne gennemgang opsummerer den videnskabelige begrundelse for klassificeringen og understregede ændringer, der har haft effekt på praksisretningslinjerne.
- Forfatterne adresserer kriterierne og betydningen af tidlige eller forløberlæsioner og identificeringen af visse lymfoide neoplasmer, der stort set er forbundet med bestemte aldersgrupper, såsom børn og ældre.
- Spørgsmålet om grænsekategorier, der har overlappende funktioner med retailer B-celle lymfomer, samt flere midlertidige enheder, gennemgås. Disse nye observationer kortlægger et kursus for fremtidig forskning på området.

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
4-RPB709Ra01 |
Cloud-Clone |
-
EUR 519.33
-
EUR 242.00
-
EUR 1672.48
-
EUR 624.16
-
EUR 1148.32
-
EUR 410.00
-
EUR 4031.20
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Rat T-Cell Leukemia/Lymphoma Protein 1A expressed in: E.coli |
TCL1A T-cell Leukemia/Lymphoma 1A Human Recombinant Protein |
PROTP56279 |
BosterBio |
Regular: 50ug |
EUR 317 |
Description: TCL1A Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 114 amino acids (1-114 a.a.) and having a molecular mass of 13.4kDa.;The TCL1A is purified by proprietary chromatographic techniques. |
Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Protein |
20-abx069248 |
Abbexa |
-
EUR 676.00
-
EUR 286.00
-
EUR 2082.00
-
EUR 801.00
-
EUR 481.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Antibody |
20-abx103881 |
Abbexa |
-
EUR 411.00
-
EUR 133.00
-
EUR 1149.00
-
EUR 565.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody |
20-abx103882 |
Abbexa |
-
EUR 439.00
-
EUR 133.00
-
EUR 1233.00
-
EUR 592.00
-
EUR 328.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody |
20-abx000786 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody |
abx433350-200ul |
Abbexa |
200 ul |
EUR 384 |
|
T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody |
20-abx313149 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody |
abx218926-100ug |
Abbexa |
100 ug |
EUR 439 |
|
T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody |
abx224110-100ug |
Abbexa |
100 ug |
EUR 411 |
|
T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody |
abx238559-100ug |
Abbexa |
100 ug |
EUR 551 |
|
Human T-cell leukemia/lymphoma protein 1A (TCL1A) ELISA Kit |
abx518206-96tests |
Abbexa |
96 tests |
EUR 668 |
|
Human TCL1A/ T-cell leukemia/lymphoma protein 1A ELISA Kit |
E2460Hu |
Sunlong |
1 Kit |
EUR 571 |
T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human) |
4-PAB709Hu01 |
Cloud-Clone |
-
EUR 239.00
-
EUR 2391.00
-
EUR 598.00
-
EUR 299.00
-
EUR 211.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
Human T-Cell Leukemia/Lymphoma Protein 1A(TCL1A)ELISA Kit |
QY-E04512 |
Qayee Biotechnology |
96T |
EUR 361 |
Human T- cell leukemia/lymphoma protein 1A, TCL1A ELISA KIT |
ELI-05546h |
Lifescience Market |
96 Tests |
EUR 824 |
T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), APC |
4-PAB709Hu01-APC |
Cloud-Clone |
-
EUR 333.00
-
EUR 3113.00
-
EUR 872.00
-
EUR 423.00
-
EUR 215.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with APC. |
T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), FITC |
4-PAB709Hu01-FITC |
Cloud-Clone |
-
EUR 287.00
-
EUR 2510.00
-
EUR 717.00
-
EUR 359.00
-
EUR 192.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with FITC. |
T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), PE |
4-PAB709Hu01-PE |
Cloud-Clone |
-
EUR 287.00
-
EUR 2510.00
-
EUR 717.00
-
EUR 359.00
-
EUR 192.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with PE. |
T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), Biotinylated |
4-PAB709Hu01-Biotin |
Cloud-Clone |
-
EUR 303.00
-
EUR 2341.00
-
EUR 697.00
-
EUR 369.00
-
EUR 216.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with Biotin. |
T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), Cy3 |
4-PAB709Hu01-Cy3 |
Cloud-Clone |
-
EUR 403.00
-
EUR 4109.00
-
EUR 1121.00
-
EUR 523.00
-
EUR 245.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with Cy3. |
T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), HRP |
4-PAB709Hu01-HRP |
Cloud-Clone |
-
EUR 305.00
-
EUR 2714.00
-
EUR 772.00
-
EUR 383.00
-
EUR 203.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with HRP. |
Mouse T-cell leukemia/lymphoma protein 1A (TCL1A) ELISA Kit |
abx518207-96tests |
Abbexa |
96 tests |
EUR 668 |
|
Mouse T- cell leukemia/lymphoma protein 1A, Tcl1a ELISA KIT |
ELI-05545m |
Lifescience Market |
96 Tests |
EUR 865 |
Recombinant human T-cell leukemia/lymphoma protein 1B |
P1275 |
FN Test |
100ug |
Ask for price |
|
Description: Recombinant protein for human T-cell leukemia/lymphoma protein 1B |
T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), APC-Cy7 |
4-PAB709Hu01-APC-Cy7 |
Cloud-Clone |
-
EUR 547.00
-
EUR 6106.00
-
EUR 1624.00
-
EUR 727.00
-
EUR 310.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with APC-Cy7. |
TCL1B T-cell Leukemia/Lymphoma 1B Human Recombinant Protein |
PROTO95988 |
BosterBio |
Regular: 20ug |
EUR 317 |
Description: TCL1B Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 151 amino acids (1-128a.a) and having a molecular mass of 17.2kDa. TCL1B is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
T-cell Leukemia / Lymphoma 1B Protein |
20-abx261196 |
Abbexa |
-
EUR 3418.00
-
EUR 328.00
-
EUR 230.00
|
|
|
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric, Trial Size |
CBA-135-T |
Cell Biolabs |
24 assays |
EUR 432 |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
CytoSelect 96-Well Cell Transformation Assay (Cell Recovery Compatible, Fluorometric), Trial Size |
CBA-140-T |
Cell Biolabs |
24 assays |
EUR 456 |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
CytoSelect 24-Well Cell Migration Assay (8 µm, Colorimetric Format), Trial Size |
CBA-100-T |
Cell Biolabs |
4 assays |
EUR 299 |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines. |
CytoSelect 24-Well Cell Migration Assay (8 µm, Fluorometric Format), Trial Size |
CBA-101-T |
Cell Biolabs |
4 assays |
EUR 299 |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines. |
CytoSelect 24-Well Cell Migration Assay (5 µm, Fluorometric Format), Trial Size |
CBA-102-T |
Cell Biolabs |
4 assays |
EUR 299 |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 5 µm pore size is ideal for monocytes / macrophages. |
CytoSelect 24-Well Cell Migration Assay (3 µm, Fluorometric Format), Trial Size |
CBA-103-T |
Cell Biolabs |
4 assays |
EUR 299 |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 3 µm pore size is best for the smallest cells including neutrophils and other leukocytes. |
CytoSelect 24-Well Cell Invasion Assay (Basement Membrane, Colorimetric Format), Trial Size |
CBA-110-T |
Cell Biolabs |
4 assays |
EUR 322 |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with ECM matrix gel (basement membrane), a protein mix isolated from EHS tumor cells. |
CytoSelect 24-Well Cell Invasion Assay (Basement Membrane, Fluorometric Format), Trial Size |
CBA-111-T |
Cell Biolabs |
4 assays |
EUR 322 |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with ECM matrix gel (basement membrane), a protein mix isolated from EHS tumor cells. |
CytoSelect 96-Well Cell Transformation Assay (Soft Agar Colony Formation), Trial Size |
CBA-130-T |
Cell Biolabs |
24 assays |
EUR 386 |
Description: Our CytoSelect 96-Well Cell Transformation Assay (Soft Agar Colony Formation) is suitable for measuring cell transformation where no downstream analysis is required. Cells are incubated in a semisolid agar medium for 7-8 days. The cells are then solubilized, lysed and detected using the included fluorescent dye in a fluorometric plate reader. |
T-cell lymphoma, 75 cases (1.1mm), set 3 |
LYM1503 |
Pantomics |
1 |
EUR 295 |
Description: Lymphoma tissue array, set 3, T-cell lymphoma, 150 cores from reactive lymphoid tissues (5 cases) and various T-cell lymphoma (68 cases) tissues in duplicates. IHC data include CD3, CD20, CD15, CD20, bcl2 et al. |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNCA1259-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), APC conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC811259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC811259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNCAP1259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNCAP1259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNCB1259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Biotin conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNCB1259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Biotin conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC471259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF647 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC471259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF647 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC551259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF555 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC551259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF555 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC431259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF543 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC431259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF543 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC881259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF488A conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC881259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF488A conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC941259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC941259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNCH1259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNCH1259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNCP1259-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), PerCP conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC041259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405S conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC041259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405S conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNCR1259-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), RPE conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNUB1259-100 |
Biotium |
100uL |
EUR 209 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Concentration: 0.2mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNUB1259-500 |
Biotium |
500uL |
EUR 458 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Concentration: 0.2mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC681259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF568 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC681259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF568 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC701259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF770 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC701259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF770 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC051259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405M conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC051259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405M conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC611259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF660R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC611259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF660R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC401259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF640R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC401259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF640R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC801259-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNC801259-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
BNUM1259-50 |
Biotium |
50uL |
EUR 395 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), 1mg/mL |
T-cell leukemia/lymphoma 6 (TCL6) polyclonal antibody |
ABP-PAB-02383 |
Allele Biotech |
100 ug |
Ask for price |
|
Værtsbakterielle interaktioner i Helicobacter pylori-infektion.
Helicobacter pylori er spiralformede gramnegative bakterier med polær flagella, der lever nær overfladen af den humane gastriske slimhinde. De har udviklet komplicerede mekanismer til at undgå bakteriedræbende syre i gastrisk lumen og for at overleve i nærheden, at binde sig til og kommunikere med det humane gastriske epitel og værtsimmunsystem.
Denne interaktion resulterer undertiden i svær gastrisk patologi. H pylori-infektion er den stærkeste kendte risikofaktor for udvikling af gastroduodenalsår, idet infektion er til stede i 60% -80% gastrisk og 95% af duodenalsår. (1) H pylori er også den første bakterie, der klassificeres som en bestemt kræftfremkaldende stof af Verdenssundhedsorganisationens internationale agentur for kræftforskning på grund af dets epidemiologiske forhold til gastrisk adenocarcinom og gastrisk slimhinde-associeret lymfoide vævslymfom.
(2) I de sidste 25 år, siden H pylori først blev beskrevet og dyrket, blev en komplet Der er sket paradigmeskift i vores kliniske tilgang til disse gastriske sygdomme, og mere finish 20.000 videnskabelige publikationer har vist sig om emnet.
Fra det medicinske synspunkt er H pylori et formidabelt patogen, der er ansvarligt for meget sygelighed og dødelighed i hele verden. Imidlertid forekommer H pylori-infektion i cirka halvdelen af verdens befolkning, hvor sygdom er en undtagelse snarere finish reglen. At forstå, hvordan denne organisme interagerer med sin vært, er essentiel for at formulere en clever strategi til håndtering af dens vigtigste kliniske konsekvenser. Denne gennemgang giver et indblik i H pylori-værtsbakterielle interaktioner.
Fremskridt og løfte om FDG-PET-billeddannelse til kræftpasienthåndtering og onkologisk lægemiddeludvikling.
2 – [(18) F] Fluoro-2-deoxyglucose-positronemissionstomografi (FDG-PET) vurderer en grundlæggende egenskab ved neoplasi, Warburg-effekten. Denne molekylære billeddannelsesteknik tilbyder en komplementær tilgang til anatomisk billeddannelse, der er mere følsom og specifik i visse kræftformer.
FDG-PET er blevet anvendt i vid udstrækning inden for onkologi primært som et iscenesættelses- og genoprettelsesværktøj, der kan vejlede patientpleje. Fordi den nøjagtigt detekterer tilbagevendende eller resterende sygdom, har FDG-PET også et betydeligt potentiale til vurdering af terapirespons. I denne forbindelse kan det forbedre patienthåndtering ved at identificere respondenter tidligt, inden tumorstørrelse reduceres; ikke-svar kan ophøre med meningsløs behandling.
- Endvidere korrelerer en reduktion i FDG-PET-signalet inden for dage eller uger efter påbegyndelse af terapi (for eksempel ved lymfom, ikke-lillecellet lunge og spiserørskræft) signifikant sammenhæng med langvarig overlevelse og andre kliniske slutpunkter, der nu anvendes i lægemiddelgodkendelser.
- Disse fund antyder, at FDG-PET kunne lette lægemiddeludvikling som et tidligt surrogat med klinisk fordel. Denne artikel gennemgår det videnskabelige grundlag for FDG-PET og dens udvikling og anvendelse som et værdifuldt værktøj til billedbehandling af onkologi.
- Dets potentiale til at lette lægemiddeludvikling i syv onkologiske omgivelser (lunge, lymfom, bryst, prostata, sarkom, kolorektal og æggestokk) behandles.
- Anbefalinger inkluderer preliminary validering mod godkendte behandlingsformer, retrospektive analyser til at definere størrelsen af ændringer, der indikerer respons, yderligere prospektiv validering som et surrogat med klinisk fordel, og anvendelse som et fase II / III-forsøgsendepunkt for at fremskynde evaluering og godkendelse af nye regimer og behandlingsformer.
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
7-04522 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
7-04523 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
7-04524 |
CHI Scientific |
1mg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
7-04525 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
7-04526 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
7-04527 |
CHI Scientific |
1mg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
7-04528 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
7-04529 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
7-04530 |
CHI Scientific |
1mg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR |
7-04537 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR |
7-04538 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR |
7-04539 |
CHI Scientific |
1mg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 XL |
7-04543 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 XL |
7-04544 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 XL |
7-04545 |
CHI Scientific |
1mg |
Ask for price |
Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2) |
4-RPA778Hu01 |
Cloud-Clone |
-
EUR 368.80
-
EUR 202.00
-
EUR 1108.00
-
EUR 436.00
-
EUR 772.00
-
EUR 310.00
-
EUR 2620.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human B-Cell Leukemia/Lymphoma 2 expressed in: E.coli |
Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2) |
4-RPA778Mu01 |
Cloud-Clone |
-
EUR 413.60
-
EUR 214.00
-
EUR 1276.00
-
EUR 492.00
-
EUR 884.00
-
EUR 340.00
-
EUR 3040.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse B-Cell Leukemia/Lymphoma 2 expressed in: E.coli |
Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2) |
4-RPA778Ra01 |
Cloud-Clone |
-
EUR 413.60
-
EUR 214.00
-
EUR 1276.00
-
EUR 492.00
-
EUR 884.00
-
EUR 340.00
-
EUR 3040.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Rat B-Cell Leukemia/Lymphoma 2 expressed in: E.coli |
B-Cell Leukemia/Lymphoma 2 |
PR27249 |
Neuromics |
5 ug |
EUR 191 |
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
DLR-Bcl2-b-48T |
DL Develop |
48T |
EUR 493 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
DLR-Bcl2-b-96T |
DL Develop |
96T |
EUR 641 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RD-Bcl2-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 494 |
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RD-Bcl2-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 684 |
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RDR-Bcl2-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 516 |
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RDR-Bcl2-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 716 |
BCL2 B-Cell Leukemia/Lymphoma 2 Human Recombinant Protein |
PROTP10415-7 |
BosterBio |
Regular: 20ug |
EUR 317 |
Description: Recombinant Human BCL2 produced in E.coli cells is a non-glycosylated, homodimeric protein containing 210 amino acid chain and having a molecular mass of 23.2kDa. The Human BCL2 is purified by proprietary chromatographic techniques. |
Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag |
7-04549 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag |
7-04550 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag |
7-04551 |
CHI Scientific |
1mg |
Ask for price |
Recombinant human B-cell lymphoma 6 protein |
P1281 |
FN Test |
100ug |
Ask for price |
|
Description: Recombinant protein for human B-cell lymphoma 6 protein |
anti-Bcl-2(B cell lymphoma 2) |
LF-PA0178 |
Abfrontier |
100 ul |
EUR 334 |
Description: Rabbit polyclonal to Bcl-2(B cell lymphoma 2) |
Bcl-2 B-Cell Leukemia/Lymphoma 2 Human Recombinant Protein (-BH4) |
PROTP10415 |
BosterBio |
Regular: 10ug |
EUR 317 |
Description: Bcl-2 Des BH4 domain (10-30 residues) Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 197 amino acids 1-9 and 31-218.;The Bcl-2 is expressed as His-Tag fusion protein and purified by proprietary chromatographic techniques. |
Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tag |
7-04531 |
CHI Scientific |
5µg |
Ask for price |
Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tag |
7-04532 |
CHI Scientific |
20µg |
Ask for price |
Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tag |
7-04533 |
CHI Scientific |
1mg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST Tag |
7-04546 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST Tag |
7-04547 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST Tag |
7-04548 |
CHI Scientific |
1mg |
Ask for price |
Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) |
4-RPL251Ca01 |
Cloud-Clone |
-
EUR 533.66
-
EUR 246.00
-
EUR 1726.24
-
EUR 642.08
-
EUR 1184.16
-
EUR 420.00
-
EUR 4165.60
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Dog B-Cell CLL/Lymphoma 2 Like Protein 2 expressed in: E.coli |
Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) |
4-RPL251Hu01 |
Cloud-Clone |
-
EUR 413.60
-
EUR 214.00
-
EUR 1276.00
-
EUR 492.00
-
EUR 884.00
-
EUR 340.00
-
EUR 3040.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human B-Cell CLL/Lymphoma 2 Like Protein 2 expressed in: E.coli |
Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) |
4-RPL251Mu01 |
Cloud-Clone |
-
EUR 485.28
-
EUR 233.00
-
EUR 1544.80
-
EUR 581.60
-
EUR 1063.20
-
EUR 388.00
-
EUR 3712.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse B-Cell CLL/Lymphoma 2 Like Protein 2 expressed in: E.coli |
Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L) |
4-RPE582Hu01 |
Cloud-Clone |
-
EUR 368.80
-
EUR 202.00
-
EUR 1108.00
-
EUR 436.00
-
EUR 772.00
-
EUR 310.00
-
EUR 2620.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human B-Cell CLL/Lymphoma 2 Like Protein expressed in: E.coli |
Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L) |
4-RPE582Mu01 |
Cloud-Clone |
-
EUR 350.88
-
EUR 197.00
-
EUR 1040.80
-
EUR 413.60
-
EUR 727.20
-
EUR 298.00
-
EUR 2452.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse B-Cell CLL/Lymphoma 2 Like Protein expressed in: E.coli |
Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L) |
4-RPE582Ra01 |
Cloud-Clone |
-
EUR 440.48
-
EUR 221.00
-
EUR 1376.80
-
EUR 525.60
-
EUR 951.20
-
EUR 358.00
-
EUR 3292.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Rat B-Cell CLL/Lymphoma 2 Like Protein expressed in: E.coli |
Human B-Cell Leukemia/Lymphoma 2 (Bcl2) Protein |
20-abx065513 |
Abbexa |
-
EUR 523.00
-
EUR 244.00
-
EUR 1497.00
-
EUR 606.00
-
EUR 384.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Recombinant human B-cell CLL/lymphoma 9 protein |
P2783 |
FN Test |
100ug |
Ask for price |
|
Description: Recombinant protein for human B-cell CLL/lymphoma 9 protein |
B-Cell Leukemia/Lymphoma 2 (Bcl-2) Antibody |
abx019019-100ug |
Abbexa |
100 ug |
EUR 342 |
|
B-Cell Leukemia/Lymphoma 2 (Bcl-2) Antibody |
abx448522-100ug |
Abbexa |
100 ug |
EUR 523 |
|
B-Cell Leukemia/Lymphoma 2 (Bcl-2) Antibody |
abx413147-01mg |
Abbexa |
0.1 mg |
EUR 439 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx133877 |
Abbexa |
-
EUR 356.00
-
EUR 537.00
-
EUR 217.00
|
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx121300 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx121846 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx125557 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx125558 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx111191 |
Abbexa |
|
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx136153 |
Abbexa |
|
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx137363 |
Abbexa |
-
EUR 704.00
-
EUR 328.00
-
EUR 230.00
|
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx109553 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
20-abx102594 |
Abbexa |
-
EUR 398.00
-
EUR 133.00
-
EUR 1107.00
-
EUR 537.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
20-abx102595 |
Abbexa |
-
EUR 411.00
-
EUR 133.00
-
EUR 1135.00
-
EUR 551.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx034669-400ul |
Abbexa |
400 ul |
EUR 523 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx034669-80l |
Abbexa |
80 µl |
EUR 286 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx038146-100ug |
Abbexa |
100 ug |
EUR 391 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx012118-100ug |
Abbexa |
100 ug |
EUR 439 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx012120-100ug |
Abbexa |
100 ug |
EUR 439 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx009552 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
20-abx000596 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx027629-400ul |
Abbexa |
400 ul |
EUR 523 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx027629-80l |
Abbexa |
80 µl |
EUR 286 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx031085-400ul |
Abbexa |
400 ul |
EUR 523 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx031085-80l |
Abbexa |
80 µl |
EUR 286 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx031231-400ul |
Abbexa |
400 ul |
EUR 523 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx031231-80l |
Abbexa |
80 µl |
EUR 286 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx016080-100ul |
Abbexa |
100 ul |
EUR 411 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx018050-100ug |
Abbexa |
100 ug |
EUR 384 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx019021-100ug |
Abbexa |
100 ug |
EUR 342 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx020100-100ug |
Abbexa |
100 ug |
EUR 439 |
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
abx431122-200ul |
Abbexa |
200 ul |
EUR 384 |
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
20-abx171393 |
Abbexa |
-
EUR 314.00
-
EUR 787.00
-
EUR 411.00
-
EUR 154.00
-
EUR 258.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
20-abx171394 |
Abbexa |
|
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
20-abx171395 |
Abbexa |
|
|
|
B-Cell Lymphoma Protein 2 alpha Protein |
20-abx262017 |
Abbexa |
-
EUR 4490.00
-
EUR 328.00
-
EUR 230.00
|
|
|
B-Cell Leukemia / Lymphoma 2 BH4 Protein |
20-abx262301 |
Abbexa |
-
EUR 328.00
-
EUR 5924.00
-
EUR 230.00
|
|
|
B-Cell Leukemia / Lymphoma 2 BH1 Protein |
20-abx262310 |
Abbexa |
-
EUR 328.00
-
EUR 5924.00
-
EUR 230.00
|
|
|
B-Cell Leukemia / Lymphoma 2 BH2 Protein |
20-abx262311 |
Abbexa |
-
EUR 328.00
-
EUR 5924.00
-
EUR 230.00
|
|
|
B-Cell Leukemia / Lymphoma 2 BH3 Protein |
20-abx262312 |
Abbexa |
-
EUR 328.00
-
EUR 5924.00
-
EUR 230.00
|
|
|
B-Cell Leukemia / Lymphoma 2 NWGR Protein |
20-abx262313 |
Abbexa |
-
EUR 328.00
-
EUR 5924.00
-
EUR 230.00
|
|
|